Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry

Table 4

In-hospital and 30 days adverse events.

	In-hospital	Discharge to 30 days	Overall
All BARC (n, %)	8 (1.7)	2 (0.4)	10 (2.1)
BARC 3–5 (n,%)	4 (0.8)	1 (0.2)	5 (1)
Death (n, %)	1 (0.2)	0 (0)	1 (0.2)
TVR (n, %)	1 (0.2)	0 (0)	1 (0.2)
Stent thrombosis (n, %)	3 (0.6)	0 (0)	3 (0.6)
IMA (n, %)	3 (0.6)	0 (0)	3 (0.6)